Form 8-K - Current report:
SEC Accession No. 0001140361-24-047166
Filing Date
2024-11-18
Accepted
2024-11-18 16:15:31
Documents
29
Period of Report
2024-11-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20038805_8k.htm   iXBRL 8-K 40895
2 EXHIBIT 99.1 ef20038805_ex99-1.htm EX-99.1 6742
6 image00006.jpg GRAPHIC 114160
7 image00007.jpg GRAPHIC 126012
8 image00008.jpg GRAPHIC 78959
9 image00009.jpg GRAPHIC 68868
10 image00010.jpg GRAPHIC 72125
11 image00011.jpg GRAPHIC 69355
12 image00012.jpg GRAPHIC 77030
13 image00013.jpg GRAPHIC 96149
14 image00014.jpg GRAPHIC 107109
15 image00015.jpg GRAPHIC 85150
16 image00016.jpg GRAPHIC 108505
17 image00017.jpg GRAPHIC 73466
18 image00018.jpg GRAPHIC 56201
19 image00019.jpg GRAPHIC 69904
20 image00021.jpg GRAPHIC 15033
  Complete submission text file 0001140361-24-047166.txt   1865166

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rckt-20241118.xsd EX-101.SCH 3994
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20241118_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20241118_pre.xml EX-101.PRE 16052
31 EXTRACTED XBRL INSTANCE DOCUMENT ef20038805_8k_htm.xml XML 4231
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 241471693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)